Altered expression of long non-coding RNAs NRON and SNHG11 in patients with ischemic stroke
Background Long non-coding RNAs, known as LncRNAs, have demonstrated a robust association with the pathogenesis of stroke. NRON and SNHG are among the most extensively studied lncRNAs in the context of atherosclerosis and inflammatory conditions. Given the absence of a current pathophysiological hypothesis regarding the potential relevance of the SNHG family and NRON lncRNAs in ischemic stroke (IS), this study aimed to investigate the altered expression of NRON and SNHG11 following atherosclerotic ischemic stroke (AIS) and their potential association with the risk of AIS. Methods Blood samples were collected from 65 AIS patients (with large artery atherosclerosis or small vessel disease) and 65 controls. The expression levels of NRON and SNHG11 were assessed within the first 24 h following the stroke using quantitative real-time PCR. Results NRON expression exhibited a significant decrease in patients compared to controls, while no substantial difference was observed in the expression level of SNHG11 between the two groups. Furthermore, logistic regression analysis revealed a significant negative association between NRON expression and the risk of AIS (adjusted odds ratio = 0.70; 95% confidence interval 0.55–0.89, P = 0.004). Conclusions These findings suggest that NRON may play a role in the pathogenesis of AIS and could potentially serve as a biomarker for the disease. To fully comprehend the mechanism underlying the association between NRON and AIS and to explore its potential therapeutic implications, further investigation is warranted..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
The Egyptian journal of medical human genetics - 25(2024), 1 vom: 25. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gharbi, Negin [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
Anmerkungen: |
© The Author(s) 2024 |
---|
doi: |
10.1186/s43042-024-00482-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR054513707 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR054513707 | ||
003 | DE-627 | ||
005 | 20240125064812.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240125s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s43042-024-00482-w |2 doi | |
035 | |a (DE-627)SPR054513707 | ||
035 | |a (SPR)s43042-024-00482-w-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gharbi, Negin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Altered expression of long non-coding RNAs NRON and SNHG11 in patients with ischemic stroke |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2024 | ||
520 | |a Background Long non-coding RNAs, known as LncRNAs, have demonstrated a robust association with the pathogenesis of stroke. NRON and SNHG are among the most extensively studied lncRNAs in the context of atherosclerosis and inflammatory conditions. Given the absence of a current pathophysiological hypothesis regarding the potential relevance of the SNHG family and NRON lncRNAs in ischemic stroke (IS), this study aimed to investigate the altered expression of NRON and SNHG11 following atherosclerotic ischemic stroke (AIS) and their potential association with the risk of AIS. Methods Blood samples were collected from 65 AIS patients (with large artery atherosclerosis or small vessel disease) and 65 controls. The expression levels of NRON and SNHG11 were assessed within the first 24 h following the stroke using quantitative real-time PCR. Results NRON expression exhibited a significant decrease in patients compared to controls, while no substantial difference was observed in the expression level of SNHG11 between the two groups. Furthermore, logistic regression analysis revealed a significant negative association between NRON expression and the risk of AIS (adjusted odds ratio = 0.70; 95% confidence interval 0.55–0.89, P = 0.004). Conclusions These findings suggest that NRON may play a role in the pathogenesis of AIS and could potentially serve as a biomarker for the disease. To fully comprehend the mechanism underlying the association between NRON and AIS and to explore its potential therapeutic implications, further investigation is warranted. | ||
650 | 4 | |a Gene expression |7 (dpeaa)DE-He213 | |
650 | 4 | |a Ischemic stroke |7 (dpeaa)DE-He213 | |
650 | 4 | |a Long non-coding RNA |7 (dpeaa)DE-He213 | |
700 | 1 | |a Mahmoudinasab, Hamideh |4 aut | |
700 | 1 | |a Hooshmandi, Etrat |4 aut | |
700 | 1 | |a Rahimi, Mousa |4 aut | |
700 | 1 | |a Bayat, Mahnaz |4 aut | |
700 | 1 | |a Karimi, Najmeh |4 aut | |
700 | 1 | |a Hojati, Seyedeh Shamim |4 aut | |
700 | 1 | |a Zayani, Zoofa |4 aut | |
700 | 1 | |a Tabrizi, Reza |4 aut | |
700 | 1 | |a Borhani-Haghighi, Afshin |0 (orcid)0000-0003-3645-9107 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Egyptian journal of medical human genetics |d Cairo : Egyptian Society of Medical Human Genetics, Medical Genetics Center, AinShams University, 2000 |g 25(2024), 1 vom: 25. Jan. |w (DE-627)SPR038848686 |w (DE-600)2515357-2 |x 2090-2441 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:1 |g day:25 |g month:01 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s43042-024-00482-w |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 1 |b 25 |c 01 |